The PROGRESS trial three years later: HOPE trial may shed some light
- PMID: 15591574
- PMCID: PMC535501
- DOI: 10.1136/bmj.329.7479.1403-d
The PROGRESS trial three years later: HOPE trial may shed some light
Comment on
-
The PROGRESS trial three years later: time for a balanced report of effectiveness.BMJ. 2004 Oct 23;329(7472):968-70. doi: 10.1136/bmj.329.7472.968. BMJ. 2004. PMID: 15499116 Free PMC article.
References
-
- The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000;342: 145-53. - PubMed
-
- Menzies Centre for Population Health Research. Profile of cardiovascular diseases, diabetes mellitus and associated risk factors in the western pacific region. Manila: World Health Organization, 1999.
-
- Materson BJ, Reda DJ, Cushman WC, Massie BM, Freis ED, Kochar MS, et al. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. N Engl J Med 1993;328: 914-21. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical